Executive Health Assessment

A physician-led, four-phase executive health assessment covering 100+ biomarkers, advanced cardiovascular markers (NMR Lipoprofile, Lp(a), ApoB, hs-CRP), comprehensive metabolic and thyroid panels, 163-gene hereditary risk testing, Galleri multi-cancer screening, and functional imaging including CT coronary calcium score, CIMT ultrasound, exercise stress test, spirometry, and home sleep study. Delivered over several weeks and concluded with a 60-minute physician debrief and written report. Optional add-ons include DEXA, VO2 max, full-body MRI with brain volumetrics, and whole genome sequencing.

My Doctor Medical Group's Executive Health Assessment is a structured, data-intensive preventive health evaluation designed for individuals who want a thorough baseline of their current health status and a personalized roadmap for long-term optimization. The program unfolds across four phases spanning several weeks. The first phase is a 60-minute physician intake — conducted by video — covering detailed medical history, family risk profiling, current medications, lifestyle factors, and the individual's specific health priorities. This intake shapes the diagnostic plan that follows. The second phase is targeted diagnostics, coordinated over the following weeks. On the laboratory side, the assessment goes well beyond standard annual blood work. The cardiovascular panel includes NMR Lipoprofile with particle size and count analysis (LDL-P, LDL size and pattern), lipoprotein(a) [Lp(a)], apolipoprotein B (ApoB), and high-sensitivity C-reactive protein (hs-CRP) — markers that the practice argues reveal significant cardiovascular risk in roughly one-third of patients whose standard lipid panels appear normal. Metabolic evaluation includes fasting insulin, hemoglobin A1c, comprehensive metabolic panel (CMP), uric acid, and homocysteine. Thyroid assessment covers TSH, Free T4, Free T3, and TPO antibodies. Micronutrient status includes vitamin D, ferritin, iron, and TIBC. Cancer screening incorporates the Galleri multi-cancer early detection test (covering 50+ cancer types from a single blood draw), PSA with reflex for men 40+, and age-appropriate coordinated screenings. For first-year participants, a 163-gene hereditary risk panel is included, covering BRCA1/2, Lynch syndrome, familial hypercholesterolemia, and metabolic conditions. Functional and imaging components include a resting EKG, exercise stress test, CT coronary calcium score, carotid intima-media thickness (CIMT) ultrasound, home sleep study, spirometry for lung function, and referrals to optometry and audiology. The third phase is an in-person comprehensive physical examination at the San Francisco office. The fourth and final phase is a 60-minute wrap-up with the physician, delivered alongside a written report and slide deck summarizing findings, risk stratification, and a prioritized action plan. Optional add-ons available at additional cost include echocardiogram, Cleerly AI-powered coronary angiogram, VO2 max testing with resting metabolic rate, comprehensive hormone panel, DEXA body composition, full-body MRI with brain volumetrics, whole genome sequencing, neurocognitive testing, 24-hour ambulatory blood pressure monitoring, pharmacogenomics, and low-dose chest CT for lung cancer screening. The assessment may support early identification of cardiovascular, metabolic, oncologic, and hereditary risks before symptoms develop.